{"nct_id":"NCT03275389","title":"A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years","status":"COMPLETED","status_verified_date":"2021-04","start_date":"2017-09-08","start_date_type":"ACTUAL","primary_completion_date":"2020-03-26","primary_completion_date_type":"ACTUAL","completion_date":"2020-03-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}